Furazolidone-containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China | |
Zhang, Guiying; Huo, Lijuan; Wang, Xuehong; Xu, Jianming; Wang, Weihong; Du, Yiqi; Lu, Hong; Liu, Wenzhong; Hong, Junbo; Zhang, Zhenyu | |
刊名 | HELICOBACTER |
2018 | |
卷号 | 23期号:5 |
关键词 | furazolidone Helicobacter pylori quadruple therapy triple therapy |
ISSN号 | 1083-4389 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3512445 |
专题 | 吉林大学白求恩第三医院 |
推荐引用方式 GB/T 7714 | Zhang, Guiying,Huo, Lijuan,Wang, Xuehong,et al. Furazolidone-containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China[J]. HELICOBACTER,2018,23(5). |
APA | Zhang, Guiying.,Huo, Lijuan.,Wang, Xuehong.,Xu, Jianming.,Wang, Weihong.,...&Lu, Nonghua.(2018).Furazolidone-containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China.HELICOBACTER,23(5). |
MLA | Zhang, Guiying,et al."Furazolidone-containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China".HELICOBACTER 23.5(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论